Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.

Oncogene - 1 Feb 2020

Chobrutskiy Boris I, Yeagley Michelle, Tipping Price, Zaman Saif, Diviney Andrea, Patel Dhruv N, Falasiri Shayan, Uversky Vladimir N, Blanck George

Abstract excerpt

Focusing on highly specific aspects of the immune response is likely to answer a number of basic questions, and in some cases even resolve basic contradictions, in cancer immunology. For example, there are many cases, where chronic inflammation is associated with cancer development, and many other cases where an immune response represents an anticancer process. In this study, using bioinformatics algorithms, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complementarity Determining Regions
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Mutation

Share to Neoplasm Grading

Source

Identifiers

PMID: 31740784
DOI: 10.1038/s41388-019-1101-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.PMID 31740784Read ↗

Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatmentsSemantic proximity Read ↗

A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates.Semantic proximity Read ↗

Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival ratesSemantic proximity Read ↗

Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.Semantic proximity Read ↗

CD171 Multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastomaSemantic proximity Read ↗

Structural insight into T cell coinhibition by PD-1H (VISTA)Semantic proximity Read ↗

Adaptive disorder as the hallmark of nanobodies antigen-binding loopsSemantic proximity Read ↗

Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival ratesSemantic proximity Read ↗

An AI-driven approach for nanobody affinity maturationSemantic proximity Read ↗

The CDR3 region as the major driver of TREM-1 interaction with its ligands, an in silico characterizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.